Rudd Report Gives AMDL, Inc. a Strong Buy Recommendation in Year-End Financial Research Report
January 06 2009 - 9:30AM
PR Newswire (US)
TUSTIN, Calif., Jan. 6 /PRNewswire-FirstCall/ -- AMDL, Inc.
(AMEX:ADL), a vertically integrated pharmaceutical company with
operations in China and the US, announced today industry analyst
Lauren Rudd has issued a strong buy recommendation for AMDL in his
year-end financial research report on the Company. The report
projects a 12-month target price of $5.00 for AMDL and highlights
the Company's: -- Consistent, positive historical financial
performance over the past four years -- Most recent operational
changes and business updates, including an updated overview of
AMDL's China-based subsidiary Jade Pharmaceuticals, Inc. -- FY2009
product pipeline -- FY2009 plans for the AMDL ELISA DR-70(R) (FDP)
cancer monitoring test; best-selling Human Placenta Extract (HPE)
anti-aging product line; and MYHPV Chip(R) diagnostic test kit
which detects approximately 28 different strains of the Human
Papilloma Virus. The research report also provides a thorough peer
group comparison with valuation analyses, views and opinions on
AMDL's projected financial performance for the 2009 fiscal year,
and historical financials. According to Mr. Rudd, "AMDL has taken
major initiatives to build its strengths while reorganizing top
management and still producing respectable financials which has
resulted in AMDL being one of the most under priced stocks we have
seen in a long time." A full copy of the report is available for
downloading online at http://www.ruddreport.com/ or by contacting
Ms. Kristine Szarkowitz, AMDL's Director Investor Relations, at .
About AMDL: Headquartered in Tustin, CA with operations in
Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its
subsidiary Jade Pharmaceutical Inc. (JPI), is a vertically
integrated pharmaceutical company devoted to the research,
development, manufacturing, and marketing of diagnostic,
pharmaceutical, nutritional supplement, and cosmetic products. The
company employs over 490 people in the U.S. and China. Forward
Looking Statements: Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995: The statements contained
in this document include certain predictions and projections that
may be considered forward-looking statements under securities law.
These statements involve a number of important risks and
uncertainties that could cause actual results to differ materially
including, but not limited to, the performance of joint venture
partners, as well as other economic, competitive and technological
factors involving the Company's operations, markets, services,
products, and prices. With respect to AMDL Inc., except for the
historical information contained herein, the matters discussed in
this document are forward-looking statements involving risks and
uncertainties that could cause actual results to differ materially
from those in such forward-looking statements. AMDL Contact:
Kristine Szarkowitz Director-Investor Relations (Tel :)
206.310.5323 DATASOURCE: AMDL, Inc. CONTACT: Kristine Szarkowitz,
AMDL Director - Investor Relations, +1-206-310-5323, Web site:
http://www.ruddreport.com/
Copyright
Amdl (AMEX:ADL)
Historical Stock Chart
From May 2024 to Jun 2024
Amdl (AMEX:ADL)
Historical Stock Chart
From Jun 2023 to Jun 2024